[go: up one dir, main page]

GB201005517D0 - Stabilised liquid formulations of polypeptides - Google Patents

Stabilised liquid formulations of polypeptides

Info

Publication number
GB201005517D0
GB201005517D0 GBGB1005517.6A GB201005517A GB201005517D0 GB 201005517 D0 GB201005517 D0 GB 201005517D0 GB 201005517 A GB201005517 A GB 201005517A GB 201005517 D0 GB201005517 D0 GB 201005517D0
Authority
GB
United Kingdom
Prior art keywords
polypeptides
liquid formulations
stabilised liquid
stabilised
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1005517.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stabilitech Ltd
Original Assignee
Stabilitech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stabilitech Ltd filed Critical Stabilitech Ltd
Priority to GBGB1005517.6A priority Critical patent/GB201005517D0/en
Publication of GB201005517D0 publication Critical patent/GB201005517D0/en
Priority to ES11714594.6T priority patent/ES2617921T3/en
Priority to HUE11714594A priority patent/HUE033656T2/en
Priority to EP11714594.6A priority patent/EP2552478B1/en
Priority to KR1020177022631A priority patent/KR101943429B1/en
Priority to GB1216473.7A priority patent/GB2490644A/en
Priority to AU2011234264A priority patent/AU2011234264B2/en
Priority to DK11714594.6T priority patent/DK2552478T3/en
Priority to US13/637,913 priority patent/US20130164296A1/en
Priority to PCT/GB2011/000493 priority patent/WO2011121301A1/en
Priority to JP2013501930A priority patent/JP5869553B2/en
Priority to BR112012025047A priority patent/BR112012025047A2/en
Priority to CN2011800181285A priority patent/CN102892427A/en
Priority to CA2795047A priority patent/CA2795047C/en
Priority to KR1020127028704A priority patent/KR101884953B1/en
Priority to IL221857A priority patent/IL221857A/en
Priority to ZA2012/06956A priority patent/ZA201206956B/en
Priority to JP2016001536A priority patent/JP6053969B2/en
Priority to AU2016202839A priority patent/AU2016202839B2/en
Priority to US15/147,114 priority patent/US10716859B2/en
Ceased legal-status Critical Current

Links

GBGB1005517.6A 2010-03-31 2010-03-31 Stabilised liquid formulations of polypeptides Ceased GB201005517D0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
GBGB1005517.6A GB201005517D0 (en) 2010-03-31 2010-03-31 Stabilised liquid formulations of polypeptides
KR1020127028704A KR101884953B1 (en) 2010-03-31 2011-03-31 Excipients for Stabilising Viral Particles, Polypeptides or Biological Material
US13/637,913 US20130164296A1 (en) 2010-03-31 2011-03-31 Excipients for Stabilising Viral Particles, Polypeptides or Biological Material
JP2013501930A JP5869553B2 (en) 2010-03-31 2011-03-31 Additives that stabilize virus particles, polypeptides or biomaterials
EP11714594.6A EP2552478B1 (en) 2010-03-31 2011-03-31 Excipients for stabilising viral particles
KR1020177022631A KR101943429B1 (en) 2010-03-31 2011-03-31 Excipients for Stabilising Viral Particles, Polypeptides or Biological Material
GB1216473.7A GB2490644A (en) 2010-03-31 2011-03-31 Excipients for stabilising viral particles, polypeptides or biological material
AU2011234264A AU2011234264B2 (en) 2010-03-31 2011-03-31 Excipients for stabilising viral particles, polypeptides or biological material
DK11714594.6T DK2552478T3 (en) 2010-03-31 2011-03-31 EXCIPIENTS FOR STABILIZING VIRUS PARTICLES
ES11714594.6T ES2617921T3 (en) 2010-03-31 2011-03-31 Excipients to stabilize viral particles
PCT/GB2011/000493 WO2011121301A1 (en) 2010-03-31 2011-03-31 Excipients for stabilising viral particles, polypeptides or biological material
HUE11714594A HUE033656T2 (en) 2010-03-31 2011-03-31 Excipients for stabilising viral particles
BR112012025047A BR112012025047A2 (en) 2010-03-31 2011-03-31 stabilized liquid formulations
CN2011800181285A CN102892427A (en) 2010-03-31 2011-03-31 Excipients for stabilising viral particles, polypeptides or biological material
CA2795047A CA2795047C (en) 2010-03-31 2011-03-31 Stabilised liquid formulations
IL221857A IL221857A (en) 2010-03-31 2012-09-09 Stabilised liquid formulations
ZA2012/06956A ZA201206956B (en) 2010-03-31 2012-09-17 Excipients for stabilising viral particle, polypeptides or biological material
JP2016001536A JP6053969B2 (en) 2010-03-31 2016-01-07 Additives that stabilize virus particles, polypeptides or biomaterials
AU2016202839A AU2016202839B2 (en) 2010-03-31 2016-05-03 Excipients for stabilising viral particles, polypeptides or biological material
US15/147,114 US10716859B2 (en) 2010-03-31 2016-05-05 Excipients for stabilising viral particles, polypeptides or biological material

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1005517.6A GB201005517D0 (en) 2010-03-31 2010-03-31 Stabilised liquid formulations of polypeptides

Publications (1)

Publication Number Publication Date
GB201005517D0 true GB201005517D0 (en) 2010-05-19

Family

ID=42228751

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1005517.6A Ceased GB201005517D0 (en) 2010-03-31 2010-03-31 Stabilised liquid formulations of polypeptides

Country Status (1)

Country Link
GB (1) GB201005517D0 (en)

Similar Documents

Publication Publication Date Title
IL265501B (en) Stabilized antibody-containing liquid formulations
IL221857A (en) Stabilised liquid formulations
SI2621468T1 (en) Pharmaceutical composition of carbetocin
GB2481881B (en) Liquid formulations
ZA201301717B (en) Liquid agricultural formulations of improved stability
SMT201900697T1 (en) Stable formulations of linaclotide
HUE064419T2 (en) Uses of marker substances
GB2474574B (en) Liquid formulation
ZA201208329B (en) Liquid formulations of rupatadine fumarate
GB2486567B (en) Pharmaceutical formulation
EP2646051A4 (en) Liquid viral formulations
ZA201305591B (en) Fluorocarbon-linked peptide formulation
ZA201206589B (en) Incotine containing formulation
GB0915480D0 (en) Stable formulation of factor viii
PL2407155T3 (en) Formulations of inecalcitol
EP2536688A4 (en) Stable dosage forms of levomilnacipran
TWM390720U (en) Structure improvement of paper-cup container
GB201005517D0 (en) Stabilised liquid formulations of polypeptides
GB201005521D0 (en) Stabilised liquid formulations of virus particles
GB201008873D0 (en) Liquid formulations
GB201013871D0 (en) Liquid formulations
GB201017648D0 (en) Liquid preparation containing stabilised viruses
TWM402710U (en) Structure of bone-ash container
TWM386065U (en) Structure of bone-ash container
TWM385541U (en) Improved structure of container

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)